Date: March 21(Thu.), 2024　1:00 pm-5:10 pm

Style: On site（UTokyoNY：145 west 57th Street 21st Floor, New York 10019）

Registration: Advanced registration is required.　Please click here.                         (https://forms.office.com/r/1in1nyG8YG)

　　　　　　　※Free adimission

 

-Program-

Facilitator： Yuichiro KUWAMA [The Mount Sinai Hospital ]

 　　　　　　Yoshiko MITO [Icahn School of Medicine at Mount Sinai]

13：00－13：10  Opening remarks / Greeting from Dean of IMSUT

                          Makoto NAKANISHI, Dean of IMSUT

13：10－13：40  Trans-ancestry genomic analysis of gastric cancer reveals unique cancer risk 

                          factors in Japanese and East Asian populations

                          Tatsuhiro SHIBATA [IMSUT]

13：40－14：25  Cancer genomics and cancer disparities research at the New York Genome Center

                          Nicolas ROBINE [New York Genome Center]

14：25－15：10  Clinical cancer genomics as a driver of advances in oncology

                          Marc LADANYI [Memorial Sloan Kettering Cancer Center ]

15：10－15：25  COFFEE BREAK

15：25－15：55  Understanding the function of non-coding DNA

                          Natsuhiko KUMASAKA [IMSUT]

15：55－16：40  Clinical applications of cell-free DNA screening by next generation sequencing

                          Yoshiko MITO [Icahn School of Medicine at Mount Sinai]

16：40－17：10  Metagenome analysis leads a paradigm shift in health/medical care

                          Seiya IMOTO [IMSUT]

17：10－17：15  Closing remarks　

17：30－18：30  Post-seminar Discussion with refreshments and drinks　

 

Organized by: The Institute of Medical Science, The University of Tokyo (IMSUT)

                       contact: intl-rel@ims.u-tokyo.ac.jp

Supported by: UTokyoNY